Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from QT Imaging Holdings ( (QTI) ).
On February 18, 2026, QT Imaging reported preliminary unaudited results showing record fourth-quarter 2025 revenue of $8.3 million, up 97% sequentially and 877% year-on-year, driven by shipments of 17 Breast Acoustic CT scanners, and full-year 2025 revenue of $18.9 million, a 288% increase that exceeded guidance. Despite lower gross margins due to higher manufacturing costs on certain units, the company improved its quarterly net loss to $1.4 million, narrowed full-year adjusted EBITDA losses, and ended 2025 with $10.5 million in cash and equivalents.
Operationally, QT Imaging shipped 40 scanners in 2025, strengthened its balance sheet via an $18.2 million private placement, uplisted to the Nasdaq Capital Market less than a year after leaving the exchange, and entered key strategic collaborations with Intelerad Medical Systems and Olea Medical to build out its QTI Cloud SaaS Platform. It also secured an exclusive UAE distribution deal with Al Naghi Medical featuring minimum orders totaling 43 scanners through 2028, appointed a new chief commercial officer, and signaled a strategic shift toward recurring SaaS and biomarker-based imaging revenues that could underpin its growth trajectory and international expansion.
The most recent analyst rating on (QTI) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTI Stock Forecast page.
Spark’s Take on QTI Stock
According to Spark, TipRanks’ AI Analyst, QTI is a Neutral.
The score is primarily held down by very weak financial performance—large losses, negative equity, and substantial ongoing cash burn—indicating elevated financial risk. Technicals are mixed but generally soft (below key shorter-term moving averages), and valuation signals are limited due to the negative P/E and lack of dividend yield data.
To see Spark’s full report on QTI stock, click here.
More about QT Imaging Holdings
QT Imaging Holdings, Inc. is a medical device company focused on transforming breast health management with its radiation-free Breast Acoustic CT scanners and a cloud-based SaaS imaging platform. The company is pivoting from a traditional scanner hardware model toward a data-centric, biomarker-driven medical imaging franchise, targeting both U.S. and international markets, including recent expansion into the Gulf region.
Average Trading Volume: 25,089
Technical Sentiment Signal: Buy
Current Market Cap: $66.71M
Learn more about QTI stock on TipRanks’ Stock Analysis page.